← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

A

$ Value

$0

Shares

3,166

Price

$0

Filed

Jun 10

Insider

Name

Saad Mark E

Title

CIK

0001295913

Roles

Director

Transaction Details

Transaction Date

2025-06-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,166

Footnotes

The options vest in full on the one-year anniversary of the date of grant, June 6, 2026. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026.

Filing Info

Accession No.

0000950170-25-084555

Form Type

4

Issuer CIK

0001579428

Saad Mark E's History

Date Ticker Type Value
2025-12-31 AXSM M $50K
2025-12-31 AXSM $1.0M
2025-12-31 AXSM M $155K
2025-12-31 AXSM $5.2M
2025-12-31 AXSM M $0
2025-12-31 AXSM M $0
2025-09-05 AXSM M $82K
2025-09-05 AXSM $1.1M
2025-09-05 AXSM M $0
2025-06-06 AXSM A $0

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22